000 | 04508cam a2200433Mi 4500 | ||
---|---|---|---|
001 | on1162860843 | ||
003 | OCoLC | ||
005 | 20240726104906.0 | ||
008 | 200702s2020 nyu ob 001 0 eng d | ||
040 |
_aYDX _beng _erda _epn _cYDX _dOCLCO _dEBLCP _dNT _dOCLCF _dUKAHL _dOCLCA _dOCLCO |
||
020 |
_a9781536179408 _q((electronic)l(electronic)ctronic) |
||
043 | _an-us--- | ||
050 | 0 | 4 |
_aRA644 _b.C676 2020 |
049 | _aMAIN | ||
245 | 1 | 0 | _aCoronavirus and U.S. public health preparedness /Roger F. Martin, editor. |
260 |
_aNew York : _bNova Science Publishers, Incorporated, _c(c)2020. |
||
300 | _a1 online resource (vi, 313 pages.). | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_adata file _2rda |
||
490 | 1 | _aPublic health in the 21st century | |
504 | _a2 | ||
505 | 0 | 0 |
_aIntro -- _tContents -- _tPreface -- _tChapter 1 -- _tOverview of U.S. Domestic Response to the 2019 Novel Coronavirus (2019-nCoV)( -- _tBackground -- _t2019 Novel Coronavirus (2019-nCoV) -- _tDomestic Response -- _tInvestigation and Control of 2019-nCoV Cases in the Community -- _tTravel Restrictions and Quarantine Requirements -- _tRestrictions and Requirements in Effect -- _tPotential Effects of Travel Restrictions on the Spread of 2019-nCoV -- _tMedical Countermeasures -- _tPotential Products for Use in the 2019-nCoV Response -- _tFDA Emergency Use Authorization (EUA) -- _tHealth System Preparedness -- _tResponse Funding |
505 | 0 | 0 |
_aChapter 2 -- _tAnother Coronavirus Emerges: -- _tU.S. Domestic Response to 2019-nCoV( -- _tThe Emergence of 2019-nCoV -- _tInfection and Transmission -- _tThe U.S. Domestic Response -- _tCase Identification and Investigation -- _tClinical Guidance -- _tTravel Notices and Entry Screening -- _tMedical Countermeasures -- _tConsiderations for Congress -- _tChapter 3 -- _tThe Coronavirus: U.S.-China Economic Considerations( -- _tEconomic Outlook -- _tGlobal Economic Impact -- _tBroader Considerations for Congress -- _tPhase One Trade Deal -- _tPharmaceutical Market Access and IP -- _tSupply Chain Vulnerabilities -- _tChapter 4 |
505 | 0 | 0 |
_aThe Wuhan Coronavirus: Assessing the Outbreak, the Response, and Regional Implications( -- _tWhat Do We Know About 2019 nCoV? -- _tWhat is Unknown? -- _tSize and Scope of the Epidemic -- _tSeverity -- _tAsymptomatic Spread -- _tInternational Response -- _tWorrisome Trends in Global Readiness for Epidemics and Pandemics -- _tRecommendations to Improve US Readiness for Continued Spread of 2019 nCoV -- _tConclusion -- _tChapter 5 -- _tWhat You Need to Know About Coronavirus Disease 2019 (COVID-19)( -- _tWhat Is Coronavirus Disease 2019 (COVID-19)? -- _tCan People in the U.S. Get COVID-19? |
505 | 0 | 0 |
_aHave There Been Cases of COVID-19 in the U.S.? -- _tHow Does COVID-19 Spread? -- _tWhat Are the Symptoms of COVID-19? -- _tWhat Are Severe Complications from This Virus? -- _tHow Can I Help Protect Myself? -- _tThere Are Simple Everyday Preventive Actions to Help Prevent the Spread of Respiratory Viruses. These Include -- _tIf You Are Sick, to Keep from Spreading Respiratory Illness to Others, You Should -- _tWhat Should I Do if I Recently Traveled to China and Got Sick? -- _tIs There a Vaccine? -- _tIs There a Treatment? -- _tChapter 6 -- _tCoronavirus Disease 2019 (COVID-19) Situation Summary( -- _tBackground |
505 | 0 | 0 |
_aSource and Spread of the Virus -- _tCOVID-19 Cases in the U.S. -- _tSituation in U.S. -- _tIllness Severity -- _tRisk Assessment -- _tWhat May Happen -- _tCDC Response -- _tHighlights of CDC's Response -- _tCDC Recommends -- _tChapter 7 -- _tScience and Tech Spotlight: Coronaviruses( -- _tWhy This Matters -- _tThe Science -- _tWhat Is It? -- _tHow Does It Work? -- _tHow Mature Is It? -- _tOpportunities -- _tChallenges -- _tPolicy Context and Questions -- _tSelected References -- _tChapter 8 -- _tCOVID-19: Current Travel Restrictions and Quarantine Measures( -- _tEntry Restrictions -- _tQuarantine and Isolation |
530 |
_a2 _ub |
||
650 | 0 |
_aCOVID-19 (Disease) _zUnited States. |
|
650 | 0 |
_aPublic health _zUnited States. |
|
650 | 0 | _aCoronavirus infections. | |
655 | 1 | _aElectronic Books. | |
700 | 1 |
_aMartin, Roger F., _e5 |
|
856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2420333&site=eds-live&custid=s3260518 _zClick to access digital title | log in using your CIU ID number and my.ciu.edu password |
942 |
_cOB _D _eEB _hRA. _m2020 _QOL _R _x _8NFIC _2LOC |
||
994 |
_a92 _bNT |
||
999 |
_c81904 _d81904 |
||
902 |
_a1 _bCynthia Snell _c1 _dCynthia Snell |